Chia Tai Enterprises International Ltd. (C.P. Pokphand) Company Profile: Board of Directors, Capital Structure, Raw Materials & More

Company CV

Chia Tai Enterprises International Ltd. (C.P. Pokphand)

Pharmaceuticals & Biotechnology

No Details Available.

No Company Details Available

Shareholding

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Board of Directors

Management

Designation

No Data

Stock DNA

Revenue and Profits:

Net Sales:

881 Million

(Quarterly Results - Jun 2026)

Net Profit:

29 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

HKD 1,981 Million ()

P/E

8.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.13

Return on Equity

9.18%

Price to Book

0.86